BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25252879)

  • 1. Health-related quality of life in primary and secondary adrenal insufficiency.
    Aulinas A; Webb SM
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):873-88. PubMed ID: 25252879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal glucocorticoid replacement in adrenal insufficiency.
    Øksnes M; Ross R; Løvås K
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):3-15. PubMed ID: 25617168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
    Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.
    Johannsson G; Falorni A; Skrtic S; Lennernäs H; Quinkler M; Monson JP; Stewart PM
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):2-11. PubMed ID: 25187037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency.
    Webb EA; Krone N
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):449-68. PubMed ID: 26051302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy.
    Dineen R; Stewart PM; Sherlock M
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):3-14. PubMed ID: 30120786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What affects the quality of life in autoimmune Addison's disease?
    Meyer G; Hackemann A; Penna-Martinez M; Badenhoop K
    Horm Metab Res; 2013 Feb; 45(2):92-5. PubMed ID: 23322510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of steroid replacement in adrenal insufficiency.
    Koetz K; Kienitz T; Quinkler M
    Minerva Endocrinol; 2010 Jun; 35(2):61-72. PubMed ID: 20595936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On Primary Adrenal Insufficiency with Normal Concentrations of Cortisol - Early Manifestation of Addison's Disease.
    Wäscher H; Knauerhase A; Klar B; Postrach T; Weber MA; Willenberg HS
    Horm Metab Res; 2024 Jan; 56(1):16-19. PubMed ID: 37918821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.
    Grossman A; Johannsson G; Quinkler M; Zelissen P
    Eur J Endocrinol; 2013 Dec; 169(6):R165-75. PubMed ID: 24031090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy.
    Ekman B; Fitts D; Marelli C; Murray RD; Quinkler M; Zelissen PM
    BMC Endocr Disord; 2014 May; 14():40. PubMed ID: 24884782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MANAGEMENT OF ENDOCRINE DISEASE: Epidemiology, quality of life and complications of primary adrenal insufficiency: a review.
    Bensing S; Hulting AL; Husebye ES; Kämpe O; Løvås K
    Eur J Endocrinol; 2016 Sep; 175(3):R107-16. PubMed ID: 27068688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal insufficiency.
    Hahner S; Ross RJ; Arlt W; Bancos I; Burger-Stritt S; Torpy DJ; Husebye ES; Quinkler M
    Nat Rev Dis Primers; 2021 Mar; 7(1):19. PubMed ID: 33707469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience.
    Ventura M; Serra-Caetano J; Cardoso R; Dinis I; Melo M; Carrilho F; Mirante A
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):721-726. PubMed ID: 31194685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addison disease: early detection and treatment principles.
    Michels A; Michels N
    Am Fam Physician; 2014 Apr; 89(7):563-8. PubMed ID: 24695602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality.
    Chabre O; Goichot B; Zenaty D; Bertherat J
    Ann Endocrinol (Paris); 2017 Dec; 78(6):490-494. PubMed ID: 29174931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Addison's disease : Primary adrenal insufficiency].
    Pulzer A; Burger-Stritt S; Hahner S
    Internist (Berl); 2016 May; 57(5):457-69. PubMed ID: 27129928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified-release prednisone decreases complaints and fatigue compared to standard prednisolone in patients with adrenal insufficiency.
    Langenheim J; Ventz M; Hinz A; Quinkler M
    Horm Metab Res; 2013 Feb; 45(2):96-101. PubMed ID: 22752958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.